Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 Infection

DOI Web Site PubMed 19 References
  • Hayashi Yasuhiro
    Faculty of Agriculture, University of Miyazaki
  • Matsuda Kouki
    Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute
  • Tanigawa Kazunari
    Faculty of Pharma-Sciences, Teikyo University
  • Tanikawa Takashi
    Faculty of Pharmacy and Pharmaceutical Sciences, Josai University
  • Maeda Kenji
    Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University
  • Tsuchiya Kiyoto
    AIDS Clinical Center, National Center for Global Health and Medicine

Search this article

Description

<p>Dihydroceramide Δ4-desaturase 1 (DEGS1) enzymatic activity is inhibited with N-(4-hydroxyphenyl)-retinamide (4-HPR). We reported previously that 4-HPR suppresses severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry through a DEGS1-independent mechanism. However, it remains unclear whether DEGS1 is involved in other SARS-CoV-2 infection processes, such as virus replication and release. Here we established DEGS1 knockout (KO) in VeroE6TMPRSS2 cells. No significant difference was observed in virus production in the culture supernatant between wild-type (WT) cells and DEGS1-KO cells, although the levels of dihydroceramide (DHCer), a DEGS1 substrate, were significantly higher in DEGS1-KO cells than WT cells. Furthermore, the virus-induced cytopathic effect was also observed in DEGS1-KO cells. Importantly, the EC50 value of 4-HPR in DEGS1-KO cells was almost identical to the value reported previously in WT cells. Our results indicated the lack of involvement of DEGS1 in SARS-CoV-2 infection.</p>

Journal

References(19)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top